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INTRODUCTION: Acute respiratory failure has been one of the most important causes of death in intensive care
units, and certain aspects of its pulmonary pathology are currently unknown.
OBJECTIVES: The objective was to describe the demographic data, etiology, and pulmonary histopathological
findings of different diseases in the autopsies of patients with acute respiratory failure.
METHOD: Autopsies of 4,710 patients with acute respiratory failure from 1990 to 2008 were reviewed, and the
following data were obtained: age, sex, and major associated diseases. The pulmonary histopathology was
categorized as diffuse alveolar damage, pulmonary edema, alveolar hemorrhage, and lymphoplasmacytic
interstitial pneumonia. The odds ratio of the concordance between the major associated diseases and specific
autopsy findings was calculated using logistic regression.
RESULTS: Bacterial bronchopneumonia was present in 33.9% of the cases and cancer in 28.1%. The pulmonary
histopathology showed diffuse alveolar damage in 40.7% (1,917) of the cases. A multivariate analysis showed a
significant and powerful association between diffuse alveolar damage and bronchopneumonia, HIV/AIDS, sepsis,
and septic shock, between liver cirrhosis and pulmonary embolism, between pulmonary edema and acute
myocardial infarction, between dilated cardiomyopathy and cancer, between alveolar hemorrhage and
bronchopneumonia and pulmonary embolism, and between lymphoplasmacytic interstitial pneumonia and HIV/
AIDS and liver cirrhosis.
CONCLUSIONS: Bronchopneumonia was the most common diagnosis in these cases. The most prevalent pulmonary
histopathological pattern was diffuse alveolar damage, which was associated with different inflammatory
conditions. Further studies are necessary to elucidate the complete pathophysiological mechanisms involved with
each disease and the development of acute respiratory failure.
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INTRODUCTION
Acute respiratory failure (ARF) is a major cause of death
in patients with a variety of primary underlying diseases. In
addition, the prevalences of comorbidities and mortality
have been reported to be higher than 40-50% in ARF
patients, especially in those with diffuse infiltrates as seen
on chest X-rays.
1-3 The clinical and radiological findings in
ARF are nonspecific,
4-6 and prompt investigation and
diagnosis are essential to improving patient survival.
7-9 In
this context, the complexity of clinical presentations makes
diagnosis a constant challenge for the clinician. Despite
recent advances, most types of diagnostic support are still
expensive. Clinicians often initiate treatment to avoid the
rapid progression of the disease and to spare the patient
from more invasive procedures. Therefore, it is important to
determine the leading causes of death in this population to
establish correct prophylactic actions, which is the least
expensive strategy for preventing further pulmonary
dysfunction and avoiding the need for lung biopsies.
10
We performed a retrospective study of 4,710 autopsies on
patients whose cause of death was ARF to better describe
the demographic and etiological data and the associated
histological pulmonary findings and diseases.
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1193MATERIAL AND METHODS
Autopsies. This study was conducted at a tertiary health
care center. From 1990 to 2008, 26,560 medical autopsies were
performed at this center, with an annual mean of 1,889. We
examined the autopsies of the 4,710 (17.7%) patients in whom
ARF was the cause of death. In 980 of these patients, the
histological pulmonary findings could not be reviewed
because the pulmonary tissue was not available (it was
classified as ‘‘without analysis’’); histological pulmonary
analyses were performed in the remaining 3,730 (79.2%)
cases. In this study, we reviewed all of the available
microscopic and macroscopic diagnoses of death at
autopsy, along with the patient medical records. The only
inclusion criterion for the definition of ARF was based on
arterial blood gases (PaO2,60 mmHg or PaCO2.50 mmHg
with pH,7.30) while breathing room air.
1-3 We excluded
patients younger than one year of age and individuals not
diagnosed with ARF.
We also obtained data regarding each patient’s age, sex,
and major underlying associated diseases (as determined at
autopsy).
The clinical data from the patients enrolled in the study
were collected with the approval of the Internal Review
Board for this study, and informed consents were obtained
from family members to perform the autopsies.
After a complete review, the pulmonary pathological
reports were categorized as follows:
Ndiffuse alveolar damage (DAD), which was defined as
diffuse involvement and a uniform temporal appearance of
alveolar collapse, hyaline membranes, obliterative fibrosis,
neo-septal formation, and moderately organizing fibrosis;
Npulmonary edema (PE), which was defined as the
accumulation of proteinaceous fluid in the alveolar spaces
that gave the appearance of a granular, pink coagulate
within such spaces;
Nalveolar hemorrhage (AH), which was defined as the
presence of blood in the alveolar spaces; and
Nlymphoplasmacytic interstitial pneumonia (LPIP), which
was defined as widened and edematous alveolar septa,
usually accompanied by a mononuclear inflammatory
infiltrate of lymphocytes, histiocytes, plasma cells, and
neutrophils.
All the lungs were analyzed by microscopy, even when
the medical records indicated the patient’s diagnosis. The
lungs were fixed in 10% formalin prepared in 0.9% saline for
at least four weeks. We studied a minimum of five sections
per lung for a total of ten sections per person, regardless of
the presence or absence of morphologically demonstrable
lesions. The paraffin-embedded tissue sections were
assessed following hematoxylin and eosin staining. To
document the presence and distribution of the wide
spectrum of infectious agents and neoplasms to which this
population was susceptible, we prepared a variety of special
stains (periodic acid-Schiff staining, immunohistochemical
analysis, fluorescence, Ziehl-Neelsen acid-fast staining,
Gram acid-fast staining, Mucicarmine acid-fast staining,
and Gomori’s methenamine silver acid-fast staining) for
selected tissue sections. Bacterial bronchopneumonia (BBP)
was defined as the presence of cell consolidation with
polymorphonuclear leukocyte accumulation in bronchioles
and adjacent alveoli. For the diagnoses of cytomegalovirus
and fungal pneumonia, histological evidence of lung
involvement was required, with or without tissue culture.
Severe sepsis and septic shock were defined as sepsis with
the addition of organ dysfunction or the clinical diagnosis of
arterial hypotension, which may or may not have been
responsible for the aggressive fluid resuscitation. The
diagnoses of Mycobacterium tuberculosis infection and atypi-
cal mycobacterial infection were confirmed using fluores-
cence, the Ziehl-Neelsen techniques and a Lowenstein-
Jensen culture. The proportion method and biochemistry
were used to identify all of the positive cultures.
Statistical analysis. The descriptive analysis of the data
included median, minimum, and maximum values. The
probabilities (odds ratios) that patients with underlying
diseases and comorbidities would develop specific pul-
monary histopathological patterns and die of ARF-related
pulmonary alterations were determined by logistic regressions.
The independent variables included the following major
diseases and/or comorbidities: BBP, cancer, liver cirrhosis,
HIV/AIDS, acute myocardial infarction, systemic arterial
hypertension, dilated cardiomyopathy, pulmonary embolism,
chronic obstructive pulmonary disease, diabetes mellitus,
sepsis and septic shock, chronic kidney failure, and
tuberculosis. All the statistical procedures were performed
using the SPSS v10.0 statistical software. Statistical significance
was set at a p-value of 5%.
RESULTS
ARF was described in 4,710 autopsies (17.7%) from 1990
to 2008. The patients’ ages ranged from 1 to 99 years (with a
median of 52). A total of 2,713 (57.6%) men and 1,997
(42.4%) women were included in the study. The demo-
graphic data are listed in Table 1.
We observed a single associated disease in 1,793 (38.0%)
of the cases, 2 diseases in 1,505 (32.0%), 3 in 797 (16.9%), 4 in
349 (7.4%) and 5 diseases in 184 (3.9%) of the cases. A
diagnosis could not be determined after autopsy in 82
(1.7%) of the cases.
The pulmonary histopathological analysis showed DAD
in 40.7% (1,917) of the patients, PE in 23.5% (1,107), AH in
10.4% (491) and LPIP in 4.6% (215) of the patients. The
pulmonary histopathological findings and the most pre-
valent diseases in the 4,710 patients are shown in Table 2.
The major underlying diseases and comorbidities in the
ARF patients are shown in Table 2. BBP was present in
33.9% of the patients (1,597 cases) and was the most
frequent pulmonary complication found at the time of
autopsy. Cancer was the second most frequent complica-
tion; it was observed in 28.1% of the patients (1,324 cases),
followed by severe sepsis and/or septic shock in 14.3%
(675), liver cirrhosis in 13.6% (639), HIV/AIDS in 10.4%
(490), pulmonary embolism in 9.0% (426), acute myocardial
Table 1 - The demographic analysis by sex and age of the
patients with acute respiratory failure who underwent
autopsies.
Sex
Age group
(years) Male Female Total
1 to 20 198 165 363 (7%)
21 to 49 1073 750 1823 (38.7%)
.50 1442 1082 2524 (53.5%)
Total 2713 (576%) 1997 (42.4%) 4710
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1194infarction in 4.7% (219), stroke in 4.4% (207), and tubercu-
losis in 2.2% (104 cases) of the patients. The main associated
comorbidities were systemic arterial hypertension in 11.5%
(541 cases), chronic kidney failure in 4.4% (207), diabetes
mellitus in 4.1% (191), dilated cardiomyopathy in 4.0%
(186), and chronic obstructive pulmonary disease in 3.5%
(164) of the patients.
The multivariate analysis, with the statistically significant
associations between the most prevalent diseases/comor-
bidities and the different histopathological findings, is
shown in Table 3.
DISCUSSION
The early and accurate treatment of ARF remains an
importantprobleminthemanagementofcriticallyillpatients.
Despite recent technological diagnostic advances, the autopsy
remains an important complementary tool for identifying and
understanding diseases. Autopsy studies have shown impor-
tant differences between autopsy findings and the antemortem
clinical diagnoses.
11-13 Such diagnostic disagreement can vary
from 10% to 90%, depending on the disease and the
population involved.
4-10,14-19 These discrepancies may be
attributable to different clinical manifestations of a single
disease or to poor-quality medical care.
4 Recently, ARF was
reported to be one of the leading causes of morbidity and
mortality in critically ill patients.
4,9,14-16 In this study, we
observed a high prevalence (17.7%) of ARF patients. Most of
thestudy patientsweremales (57%),and the mean age was 52
years. Others studies have shown similar results.
4,9,14-16 A
retrospective study carried out between 1996 and 2002 in 58
patients with DAD diagnosed by surgical lung biopsy found
that 52% of the patients were male and that the mean age was
61 years.
20
We observed a single disease in 38% of the patients with
ARF and two or more diseases in 62% of the patients. The
Table 2 - The etiological diagnoses observed in the autopsies of the acute respiratory failure patients, along with the
main pulmonary histopathological findings.
Disease DAD PE AH LPIP Without analysis Total (%)
BBP 572 264 145 78 538 1597 33.9%
Cancer 500 280 157 36 351 1324 28.1%
Severe sepsis and/or septic shock 414 76 60 26 99 675 14.3%
Liver cirrhosis * 407 103 65 14 50 639 13.6%
Systemic arterial hypertension 172 181 52 13 123 541 11.5%
HIV/AIDS 152 47 44 115 132 490 10.4%
Pulmonary embolism 68 102 77 10 169 426 9.0%
Acute myocardial infarction 38 159 4 0 18 219 4.7%
Brain stroke 97 61 15 1 33 207 4.4%
Chronic kidney failure 88 56 21 7 35 207 4.4%
Diabetes mellitus 69 51 15 6 50 191 4.1%
Dilated cardiomyopathy 39 90 17 5 35 186 4.0%
COPD 35 39 20 3 67 164 3.5%
Tuberculosis 33 16 9 7 39 104 2.2%
*=No cause identified; DAD=Diffuse alveolar damage; PE=Pulmonary edema; AH=Alveolar hemorrhage; LPIP=Lymphoplasmacytic interstitial
pneumonia; BBP=Bacterial bronchopneumonia; HIV/AIDS=Human immunodeficiency virus/acquired immunodeficiency syndrome; COPD=Chronic
obstructive pulmonary disease.
Table 3 - The multivariate analysis of the main associated diseases found in the autopsies of the patients with acute
respiratory failure, showing the relationships with the respective pulmonary histopathological findings.
DAD PE AH LPIP
OR p** CI 95% OR p** CI 95% OR p** CI 95% OR p** CI 95%
BBP 1.5 ,0.001 1.31–1.72 1.64 ,0.001 1.39–1.93 1.24 0.04 1.00–1.53 1.21 NS 0.88–1.65
HIV/AIDS 2.14 ,0.001 1.72–2.68 2.04 ,0.001 1.47–2.82 1.4 NS 0.99 – 1.97 10.05 ,0.001 7.16–14.11
Severe sepsis and/or
septic shock
2.67 ,0.001 2.24–3.20 2.29 ,0.001 1.77–2.96 1.19 NS 0.89 – 1.58 1.5 NS 0.95–2.37
Liver cirrhosis 2.24 ,0.001 1.86–2.70 1.69 ,0.001 1.33–2.14 1.06 NS 0.79 – 1.42 2.01 0.02 1.14–3.55
Cancer 1.09 NS 0.94–1.26 1.27 0.006 1.07–1.50 1.23 NS 0.99 – 1.52 1.33 NS 0.90–1.96
Pulmonary embolism 3.67 ,0.001 2.79–4.85 1.22 NS 0.95–1.56 2.14 ,0.001 1.62 – 2.82 1.64 NS 0.84–3.19
Acute myocardial
infarction
3.14 ,0.001 2.18–4.54 6.19 ,0.001 4.50–8.52 5.67 0.001 2.08 – 15.44 4.94 NS 0.71–6.32
Systemic arterial
hypertension
1.02 NS 0.73–1.44 1.3 NS 0.90–1.90 1.14 NS 0.67 – 1.94 0.54 NS 0.24–1.20
Dilated
cardiomyopathy
2.3 ,0.001 1.58–3.34 2.54 ,0.001 1.84–3.49 1.05 NS 0.62 – 1.76 1.03 NS 0.41–2.60
COPD 2.04 0.001 1.36–3.05 1.38 NS 0.93–2.04 1.58 NS 0.96 – 2.60 1.4 NS 0.43–4.55
Diabetes mellitus 1.13 NS 0.81–1.58 1.07 NS 0.75–1.54 1.03 NS 0.64 – 1.64 0.95 NS 0.39–2.32
Chronic kidney
failure
1.11 NS 0.82–1.51 1.38 NS 0.98–1.94 0.98 NS 0.61 – 1.57 1 NS 0.45–2.24
Tuberculosis 1.54 NS 0.98–2.40 1.22 NS 0.70–2.14 1.24 NS 0.61 – 2.49 1.48 NS 0.65–3.35
OR=Odds ratio; CI=Confidence interval; DAD=Diffuse alveolar damage; PE=Pulmonary edema; AH=Alveolar hemorrhage; LPIP=Lymphoplasmacytic
interstitial pneumonia; BBP=Bacterial bronchopneumonia; HIV/AIDS=Human immunodeficiency virus/acquired immunodeficiency syndrome;
COPD=Chronic obstructive pulmonary disease; NS=Not statistically significant; * = No cause identified.
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1195high prevalence of multiple diagnoses illustrates the
complexity and critical status of the patients that presented
with ARF as the cause of death; it may indicate the need for
a different therapeutic strategy with these patients.
21-22
Our study specifically showed that the patients who
developed ARF had underlying diseases such as BBP
(33.9%), cancer (28.1%), sepsis and septic shock (14.3%), liver
cirrhosis (13.6%), HIV/AIDS (10.4%), pulmonary embolism
(9.0%), acute myocardial infarction (4.7%), brain stroke
(4.4%), chronic kidney failure (4.4%), and diabetes mellitus
(4.1%). Infectious diseases were the most common diagnoses,
as has also been described by other authors.
6,9,14-20,23,24
Interestingly, these findings are not consistent with our
previously published study in 2008 that reported related
cases of ARF in autopsies from 1990 to 2000 only; it reported
the following associated diseases or complications in
descending order: HIV/AIDS (31.4%), BBP (21.8%), sepsis
and septic shock (11.7%), liver cirrhosis (11.5%), pulmonary
embolism (5.7%), acute myocardial infarction (5.5%), brain
stroke (4.6%), tuberculosis (3.6%), cancer (2.3%), chronic
kidney failure (1.9%), and leukemia (0.2%).
22
BBP was present in 33.9% of the patients and was the
most frequent pulmonary complication found during
autopsy. Frequently, the ARF patients had BBP as the initial
cause of pulmonary disease, but BBP often occurs as a
complication of other pathologies, usually in immunocom-
promised and intubated patients. Other studies have
described similar findings and reported BBP as the most
common disease in ARF patients.
20,23-25 Gross et al
25
analyzed 234 autopsies of elderly patients and found that
33% of them had BBP, which is exactly the same prevalence
observed in our study but in an elderly-only population.
25
Cancer was the second most important complication
diagnosis in our study; it was present in 28.1% of the
autopsies. This incidence rate was higher than that observed
in other studies.
25 The most interesting observation was the
increase compared with the incidence found in our
previously published survey (2.3%).
22 This finding suggests
that the number of diagnoses and the severity of cancer
presentations have increased. These patients had been
exposed to immunocompromised conditions from the use
of quimioterapic agents and anorexia. Both these conditions
increase the risk of associated infections, which are one of
the major causes of death in this population.
20,26
Consequently, pulmonary manifestations are one of the
most common causes of death in these patients; there is a
high incidence of BBP, including atypical bacterias.
20,25,26
In this study, HIV/AIDS was present in 10.4% of the
patients with ARF. Pulmonary involvement has been
reported in between 80 and 94% of the patients with HIV/
AIDS. The classical evolution of patients with HIV/AIDS to
ARF and its importance have been reported in several other
studies.
11-13,21,22 As in patients with cancer, immunocom-
promised conditions substantially increase the risk of
infection. Associated bacterial BBP is the major cause of
respiratory failure, but tuberculosis, cytomegalovirus and
Pneumocystis jiroveci pneumonia are also important causes of
pulmonary commitment.
11-13,21 In contrast to our previous
publication, the rate of HIV/AIDS infection has declined
over the last ten years from 16-31% to only 10.4%.
21,22
Modern diagnostic methods, antibiotics and antiretroviral
therapy have been reported to be the major causes of this
modification of the HIV/AIDS prevalence in critically ill
patients.
21
We observed liver cirrhosis in 13.6% of the autopsies in
this study; a similar association in ARF patients was not
found in the literature. We realize that liver cirrhosis can
result in an immunocompromised or inflammatory status
similar to that of other pathologies and predispose patients
to infectious diseases.
Others diseases, such as pulmonary embolism and acute
myocardial infarction, were significantly associated with
ARF. The underdiagnosis of pulmonary embolism has been
a significant problem in critical care units until recently.
22
Based on the pulmonary histopathological analysis, DAD
was the most common pattern observed (40.7% of cases),
which is consistent with our previous study.
22 No similar
results have been previously found in other studies of ARF
patients. Parambil et al
20 described a 90% prevalence of
DAD in patients with acute respiratory distress syndrome
who underwent surgical lung biopsies.
20,27 However, these
findings are consistent with the higher prevalence and the
significant association with BBP of sepsis and/or septic
shock, HIV/AIDS and other infectious and inflammatory
diseases. Other contributing factors include impeded
mechanical ventilation, which can accelerate the develop-
ment of these histopathologies.
21,22 Unexpectedly, DAD was
also associated with conditions such as liver cirrhosis, acute
myocardial infarction, pulmonary embolism, dilated cardi-
omyopathy and chronic obstructive pulmonary disease. We
did not find that this association has been reported
elsewhere in the literature, and it probably indicates that a
common inflammatory response is present in these distinct
pathologies.
As expected, PE was mostly associated with myocardial
infarction and dilated cardiomyopathy; regardless, isolated
PE was still observed and was associated with almost all of
the major diseases studied. PE was the most specific pattern
in the cancer patients, a finding that has not been previously
reported.
AH was present in 10.4% of the patients and was
associated with BBP and pulmonary embolism. We think
that the association with myocardial infarction is not as
relevant because of the small number of patients (four
cases). AH was also associated with severe pulmonary
complications and the presence of large necrotic areas and
hemorrhaging, as is expected to result in cases of massive
pulmonary embolism.
22 One group has described pulmon-
ary embolisms in 5% of the patients who died from ARF.
14
Two other groups have reported pulmonary embolisms in
14% and 20% of the patients who died from ARF.
15,16
Finally, LPIP showed an important association and was
the most specific pattern in the HIV/AIDS patients, a
finding that has been previously reported.
11-13,21 These
findings are consistent with the higher prevalence of
opportunistic infections, mainly viral, fungal and mycobac-
terial, that frequently cause LPIP to develop.
21,28 Liver
cirrhosis was also associated with LPIP, although the
possible reasons are unknown.
Limitations
First and foremost, this was a retrospective study of
medical records in which the quality of the information was
inherently limited. The second limitation of our study is
related to the interobserver variability, which is an issue
even though all of the autopsies at our institution are
performed by a resident pathologist and supervised by a
senior pathologist, who also checks the histological analysis
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1196to prepare the final reports. Different observers can have
different opinions; some studies have shown significant
interobserver variability in about 15% to 35% of the
autopsies analyzed.
4,7 In addition, the accuracy of autopsy
findings depends on the interest and skill of the pathologist.
CONCLUSIONS
Despite recent advances in diagnostic technological, the
autopsy has remained an important complementary tool for
identifying and understanding diseases in ARF patients.
BBP was the most common diagnosis in our ARF patients,
followed by cancer. The most prevalent pulmonary histo-
pathological pattern was DAD, which was associated with
different inflammatory conditions.
Further studies are necessary to elucidate the complete
pulmonary pathophysiological mechanisms involved in
each disease and in the development of ARF.
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